Kari Johansen

Summary

Affiliation: Swedish Institute for Infectious Disease Control
Country: Sweden

Publications

  1. ncbi Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants
    Kari Johansen
    Department of Virology, Swedish Institute for Infectious Disease Control, Karolinska Institute, S 171 82, Solna, Sweden
    Vaccine 21:368-75. 2003
  2. doi Complications attributable to rotavirus-induced diarrhoea in a Swedish paediatric population: report from an 11-year surveillance
    Kari Johansen
    Department of Virology, Swedish Institute for Infectious Disease Control, Solna, Sweden
    Scand J Infect Dis 40:958-64. 2008
  3. ncbi [Rotavirus vaccine can reduce the burden of illness. Decision on inclusion in the child vaccination program needs more data]
    Kari Johansen
    Smittskyddsinstitutet, Stockholm
    Lakartidningen 105:1169. 2008
  4. doi Norovirus strains belonging to the GII.4 genotype dominate as a cause of nosocomial outbreaks of viral gastroenteritis in Sweden 1997--2005. Arrival of new variants is associated with large nation-wide epidemics
    Kari Johansen
    Department of Virology, Immunology and Vaccinology, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden
    J Clin Virol 42:129-34. 2008
  5. doi Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea
    Neha Pant
    Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
    Future Microbiol 6:583-93. 2011
  6. doi Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes
    Maria Kakoulidou
    Department of Virology, Swedish Institute for Infectious Disease Control, Solna, Sweden
    Vaccine 28:1002-7. 2010
  7. ncbi Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea
    Neha Pant
    Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska Huddinge, Stockholm, Sweden
    J Infect Dis 194:1580-8. 2006
  8. pmc Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype
    Mikael Nilsson
    Department of Virology, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden
    J Virol 77:13117-24. 2003
  9. doi Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults
    Maria Kakoulidou
    Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
    Vaccine 31:711-7. 2013
  10. doi Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant
    Andreas Brave
    Swedish Institute for Infectious Disease Control and Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden
    Vaccine 26:5957-66. 2008

Collaborators

Detail Information

Publications19

  1. ncbi Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants
    Kari Johansen
    Department of Virology, Swedish Institute for Infectious Disease Control, Karolinska Institute, S 171 82, Solna, Sweden
    Vaccine 21:368-75. 2003
    ..E.M.+/-10750). All offsprings to immunized dams were protected against clinical diarrhea upon oral challenge with RRV. The IgG1/IgG2a ratio was in all immunized groups approximately 1 suggesting development of a balanced Th1/Th2 response...
  2. doi Complications attributable to rotavirus-induced diarrhoea in a Swedish paediatric population: report from an 11-year surveillance
    Kari Johansen
    Department of Virology, Swedish Institute for Infectious Disease Control, Solna, Sweden
    Scand J Infect Dis 40:958-64. 2008
    ..05). Interestingly, the age of children developing seizures and signs of encephalitis was significantly higher than in children with no complications (p<0.01)...
  3. ncbi [Rotavirus vaccine can reduce the burden of illness. Decision on inclusion in the child vaccination program needs more data]
    Kari Johansen
    Smittskyddsinstitutet, Stockholm
    Lakartidningen 105:1169. 2008
  4. doi Norovirus strains belonging to the GII.4 genotype dominate as a cause of nosocomial outbreaks of viral gastroenteritis in Sweden 1997--2005. Arrival of new variants is associated with large nation-wide epidemics
    Kari Johansen
    Department of Virology, Immunology and Vaccinology, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden
    J Clin Virol 42:129-34. 2008
    ..In recent years an increase of the incidence of nosocomial outbreaks caused by noroviruses has been observed throughout Sweden, with high peaks noted in the winter seasons 2002/2003 and 2004/2005, respectively...
  5. doi Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea
    Neha Pant
    Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
    Future Microbiol 6:583-93. 2011
    ..Using genetically engineered lactobacilli, producing high avidity llama VHH domains (referred to as anti-rotavirus proteins; ARPs), to test the effect of multimeric antibody fragments as prophylaxis and therapy against rotavirus infection...
  6. doi Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes
    Maria Kakoulidou
    Department of Virology, Swedish Institute for Infectious Disease Control, Solna, Sweden
    Vaccine 28:1002-7. 2010
    ....
  7. ncbi Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea
    Neha Pant
    Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska Huddinge, Stockholm, Sweden
    J Infect Dis 194:1580-8. 2006
    ..We therefore developed a system for passive immunotherapy in which recombinant lactobacilli constitutively express neutralizing variable domain of llama heavy-chain (VHH) antibody fragments against rotavirus...
  8. pmc Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype
    Mikael Nilsson
    Department of Virology, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden
    J Virol 77:13117-24. 2003
    ....
  9. doi Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults
    Maria Kakoulidou
    Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
    Vaccine 31:711-7. 2013
    ..It remains to be shown if memory B-cells provide the same protection as specific antibodies, but our data is a valuable complement to the incomplete knowledge about correlates of protection after vaccination...
  10. doi Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant
    Andreas Brave
    Swedish Institute for Infectious Disease Control and Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden
    Vaccine 26:5957-66. 2008
    ..These data show that HIV-1 DNA-plasmid immunization during breast-feeding and recombinant protein boosting shortly thereafter enhance the breadth of humoral HIV-1-specific immune responses...
  11. ncbi [Rubella still a problem in Europe--important that pregnant women have an adequate protection]
    Kari Johansen
    Klinisk virologi och pediatrik, avdelningen för virologi avdelningen för immunologi och vaccinologi, Smittskyddsinstitutet, Solna
    Lakartidningen 101:3994-6, 3998-9. 2004
  12. ncbi Identification of viral agents associated with diarrhea in young children during a winter season in Beijing, China
    Chunyan Liu
    Virology Laboratory, Beijing Pediatric Research Institute, Beijing Children s Hospital Affiliated to Capital University of Medical Sciences, Beijing, China
    J Clin Virol 35:69-72. 2006
    ..Viral diarrhea remains a major cause of childhood morbidity and mortality worldwide. Although rotavirus was extensively studied in China, few comprehensive studies of all viral agents related to diarrhea in children have been conducted...
  13. ncbi Rotavirus vaccines: considerations for successful implementation in Europe
    Pierre Van Damme
    Centre for the Evaluation of Vaccination, University of Antwerp, Belgium
    Lancet Infect Dis 6:805-12. 2006
    ..Further studies on the cost of the disease and the benefit of vaccination, together with raising awareness are necessary steps to ensure successful implementation of rotavirus vaccination in Europe...
  14. doi Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice
    Claudia Istrate
    Instituto de Biologia Experimental e Tecnologica and Instituto de Tecnologia Quimica e Biologica, SE 171 76 Oeiras, Portugal
    Vaccine 26:4594-601. 2008
    ..Passive protective immunity was achieved in offspring to dams vaccinated with 2 and 20 microg RV-VLPs in presence of adjuvant and 20 microg RV-VLP without adjuvant...
  15. ncbi Passive immunity against measles in infants: is there a need for policy changes in the European vaccination schedules?
    Kari Johansen
    Euro Surveill 12:E3-4. 2007
  16. ncbi European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus
    Fernando de Ory
    Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    J Clin Virol 36:111-8. 2006
    ..The aim of the European Sero-Epidemiology Network (ESEN2) is to harmonise the serological surveillance of vaccine-preventable diseases in Europe...
  17. pmc Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts
    Iyadh Douagi
    Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Box 280, S 171 77 Stockholm, Sweden
    J Virol 81:2758-68. 2007
    ..However, in contrast to MEFs, this action was not sufficient to completely abrogate type I IFN induction, consistent with a role for DCs as sentinels for virus infection...
  18. pmc Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets
    Anthony Nardone
    Centre for Infections, Health Protection Agency, London, England
    Bull World Health Organ 86:118-25. 2008
    ..To standardize serological surveillance to compare rubella susceptibility in Australia and 16 European countries, and measure progress towards international disease-control targets...
  19. pmc High genetic diversity of measles virus, World Health Organization European Region, 2005-2006
    Jacques R Kremer
    World Health Organization WHO Regional Reference Laboratory for Measles and Rubella, Laboratoire National de Santé Immunology 20A, rue Auguste Lumiere, Luxembourg, Luxembourg
    Emerg Infect Dis 14:107-14. 2008
    ..Thus, despite the reduction of endemic MV circulation, importation of MV from other continents caused prolonged circulation and large outbreaks after their introduction into unvaccinated and highly mobile communities...